Fig. 3

Brain weight to body weight ratios (A) and kidney weight to body weight ratios (B) among treatment groups. Values are mean \(\pm\) SEM (N = 225 fetuses; n = 52 CON d 60 fetuses, n = 60 Cr d 60 fetuses, n = 54 CON d 90 fetuses, and n = 59 Cr d 90 fetuses). Fetuses from creatine supplemented gilts had heavier brain weight to body weight ratios than those from CON treated gilts on d 90 of gestation (P < 0.05). Fetuses from creatine supplemented gilts had greater kidney weight to body weight ratios as compared to those for fetuses from CON gilts on d 60 of gestation (P < 0.01)